Clinical and therapeutic implications of presymptomatic gene testing for familial amyloidotic polyneuropathy (FAP)
Rights managed by Taylor & Francis
| Autor principal: | |
|---|---|
| Outros Autores: | , |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2021
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10451/48466 |
| País: | Portugal |
| Oai: | oai:repositorio.ul.pt:10451/48466 |